-+ 0.00%
-+ 0.00%
-+ 0.00%
According to Zhitong Finance App, Deshijia (01846.HK) announced that on November 16, 2026 (after the trading period), Shanghai Deshijia Ophthalmology Co., Ltd., Guangzhou Deshijia Ophthalmology Clinic Co., Ltd. and Beijing Deshijia Ophthalmology Clinic Co., Ltd. will each acquire 30% of their shares in Shanghai Lingrui Enterprise Development Co., Ltd., at a total cost of RMB 33.23 million. While such acquisitions are being carried out, each of these target companies will implement capital cuts to cancel their respective target shares. Upon completion, the seller will no longer hold any shares in such target companies, which will become wholly-owned subsidiaries of the companies.
Share
Listen to the news
According to Zhitong Finance App, Deshijia (01846.HK) announced that on November 16, 2026 (after the trading period), Shanghai Deshijia Ophthalmology Co., Ltd., Guangzhou Deshijia Ophthalmology Clinic Co., Ltd. and Beijing Deshijia Ophthalmology Clinic Co., Ltd. will each acquire 30% of their shares in Shanghai Lingrui Enterprise Development Co., Ltd., at a total cost of RMB 33.23 million. While such acquisitions are being carried out, each of these target companies will implement capital cuts to cancel their respective target shares. Upon completion, the seller will no longer hold any shares in such target companies, which will become wholly-owned subsidiaries of the companies.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending